方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 群体药效学模型× | Schild 分析× | |
|---|---|---|
| 领域 | 药理学 | 药理学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1992 | 1947 |
| 提出者≠ | Lewis Sheiner and Stephen Roush | Henry Schild |
| 类型≠ | dose-response modeling | antagonism quantification |
| 开创性文献≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism. Journal of Physiology, 106(3), 337-357. DOI ↗ |
| 别名≠ | PopPD, population PD, hierarchical PD modeling | Schild plot, pA2 |
| 相关 | 3 | 3 |
| 摘要≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | Schild analysis is a quantitative method for characterizing competitive receptor antagonism developed by Henry Schild in 1947. It uses dose-response curves in the presence and absence of antagonist to estimate the antagonist affinity constant (pA2), enabling standardized comparison of antagonist potency across drugs and experimental systems. |
| ScholarGate数据集 ↗ |
|
|